Regeneron Pharmaceuticals, Inc. (ETR:RGO)
634.00
-9.20 (-1.43%)
At close: Jan 28, 2026
30.64% (1Y)
| Market Cap | 64.03B -12.9% |
| Revenue (ttm) | 12.22B +1.0% |
| Net Income | 3.84B +2.1% |
| EPS | 35.33 +8.2% |
| Shares Out | n/a |
| PE Ratio | 16.69 |
| Forward PE | 15.39 |
| Dividend | 3.40 (0.54%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 27 |
| Average Volume | 136 |
| Open | 641.20 |
| Previous Close | 643.20 |
| Day's Range | 634.00 - 641.20 |
| 52-Week Range | 464.70 - 702.60 |
| Beta | n/a |
| RSI | 40.71 |
| Earnings Date | Jan 30, 2026 |